| Tap a line for its trend | Last 12Mto Sep 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 70.90× | 70.90× | 180.08× | 303.11× | 436.36× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 0.18× | 0.18× | 0.15× | 0.14× | 0.10× | ||
| −3.37× | −3.37× | 0.85× | — | — | ||
| −8.08× | −8.08× | −7.38× | — | — |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/09/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 436.36 | 303.11 | 180.08 | 70.90 | 70.90 | |
| Asset Turnover | 0.10 | 0.14 | 0.15 | 0.18 | 0.18 | |
| Cash Conversion (CFO/Net Income) | — | — | 0.85 | -3.37 | -3.37 | |
| CFO/EBITDA | — | — | -7.38 | -8.08 | -8.08 |